Changes related to "Tutorial"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 01:04, 21 June 2018
   
Page name:

20 June 2018

 m   15:13  Breast cancer, HER2-positive‎ (diff | hist) . . (-118). . Jwarner (talk | contribs)
     15:05  Breast cancer‎‎ (6 changes | history) . . (+3,855). . [Jwarner‎ (6×)]
 m    15:05 (cur | prev) . . (+17). . Jwarner (talk | contribs) (Variant #1, 20 mg/m2 weekly {{#subobject:96cac2|Variant=1}})
 m    11:01 (cur | prev) . . (-8). . Jwarner (talk | contribs) (Paclitaxel monotherapy, q3wk {{#subobject:3e5448|Regimen=1}})
 m    11:00 (cur | prev) . . (+1,748). . Jwarner (talk | contribs) (Gemcitabine & Bevacizumab {{#subobject:134dbe|Regimen=1}})
      10:56 (cur | prev) . . (+2,990). . Jwarner (talk | contribs) (Metastatic disease, maintenance after first-line therapy)
 m    10:52 (cur | prev) . . (+1,616). . Jwarner (talk | contribs) (Gemcitabine monotherapy {{#subobject:b240d6|Regimen=1}})
 m    10:49 (cur | prev) . . (-2,508). . Jwarner (talk | contribs) (GT (Taxol) {{#subobject:1285e|Regimen=1}})
 m   14:54  Autologous HSCT‎ (diff | hist) . . (+20). . Jwarner (talk | contribs) (References)
 m   14:53  Diffuse large B-cell lymphoma‎‎ (3 changes | history) . . (+491). . [Jwarner‎ (3×)]
 m    14:53 (cur | prev) . . (+213). . Jwarner (talk | contribs)
 m    13:43 (cur | prev) . . (+2,393). . Jwarner (talk | contribs) (R-DHAP {{#subobject:18c266|Regimen=1}})
 m    13:37 (cur | prev) . . (-2,115). . Jwarner (talk | contribs) (ROAD {{#subobject:0d0c67|Regimen=1}})
 m   11:57  Mantle cell lymphoma‎ (diff | hist) . . (+105). . Jwarner (talk | contribs)
 m   11:11  Multiple myeloma‎ (diff | hist) . . (+6). . Jwarner (talk | contribs)
 m   10:43  Colon cancer‎ (diff | hist) . . (+288). . Jwarner (talk | contribs)

19 June 2018

 m   17:42  Diffuse large B-cell lymphoma - historical‎‎ (4 changes | history) . . (+704). . [Jwarner‎ (4×)]
 m    17:42 (cur | prev) . . (+28). . Jwarner (talk | contribs) (Relapsed or refractory, further lines of therapy)
 m    17:39 (cur | prev) . . (+352). . Jwarner (talk | contribs) (Relapsed or refractory, salvage therapy)
 m    17:17 (cur | prev) . . (+1,211). . Jwarner (talk | contribs) (MINE {{#subobject:aff118|Regimen=1}})
 m    17:17 (cur | prev) . . (-887). . Jwarner (talk | contribs) (NOAC {{#subobject:c6c400|Regimen=1}})
 m   17:24  Breast cancer‎ (diff | hist) . . (-260). . Jwarner (talk | contribs)
 m   16:32  Autologous HSCT‎ (diff | hist) . . (+89). . Jwarner (talk | contribs) (Low-dose conditioning regimens for cellular therapy, all lines of therapy)
 m   15:48  Breast cancer, HER2-positive‎ (diff | hist) . . (+5,862). . Jwarner (talk | contribs) (Adjuvant chemotherapy)
 m   11:26  Multiple myeloma‎ (diff | hist) . . (+1,082). . Jwarner (talk | contribs)

18 June 2018

 m   23:15  Complex multipart regimens‎ (diff | hist) . . (0). . Jwarner (talk | contribs)
 m   20:54  Diffuse large B-cell lymphoma - historical‎‎ (3 changes | history) . . (-593). . [Jwarner‎ (3×)]
 m    20:54 (cur | prev) . . (+596). . Jwarner (talk | contribs) (C-MOPP {{#subobject:5c18a1|Regimen=1}})
 m    20:53 (cur | prev) . . (-1,298). . Jwarner (talk | contribs) (COPP (Cyclophosphamide) {{#subobject:d52969|Regimen=1}})
 m    20:52 (cur | prev) . . (+109). . Jwarner (talk | contribs) (C-MOPP {{#subobject:5c18a1|Regimen=1}})
 m   20:39  Autologous HSCT‎‎ (7 changes | history) . . (+1,114). . [Jwarner‎ (7×)]
 m    20:39 (cur | prev) . . (+2,126). . Jwarner (talk | contribs) (Bu/TT {{#subobject:e04a91|Regimen=1}})
 m    20:38 (cur | prev) . . (-2,106). . Jwarner (talk | contribs) (TBC {{#subobject:e04a91|Regimen=1}})
 m    17:57 (cur | prev) . . (+1,577). . Jwarner (talk | contribs) (Busulfan & Melphalan {{#subobject:484436|Regimen=1}})
 m    17:57 (cur | prev) . . (-1,577). . Jwarner (talk | contribs) (Busulfan & Cyclophosphamide {{#subobject:9acbe9|Regimen=1}})
 m    17:56 (cur | prev) . . (-90). . Jwarner (talk | contribs) (Bu/Cy {{#subobject:9acbe9|Regimen=1}})
 m    17:35 (cur | prev) . . (+75). . Jwarner (talk | contribs) (Bortezomib & Melphalan {{#subobject:9c28bc|Regimen=1}})
 m    17:34 (cur | prev) . . (+1,109). . Jwarner (talk | contribs) (Bor-HDM {{#subobject:9c28bc|Regimen=1}})
 m   17:42  Multiple myeloma‎‎ (5 changes | history) . . (-83). . [Jwarner‎ (5×)]
 m    17:42 (cur | prev) . . (-94). . Jwarner (talk | contribs)
 m    17:41 (cur | prev) . . (+3,384). . Jwarner (talk | contribs) (VT {{#subobject:e94510|Regimen=1}})
 m    17:37 (cur | prev) . . (-3,293). . Jwarner (talk | contribs) (Bortezomib & Prednisone {{#subobject:ee2988|Regimen=1}})
 m    17:13 (cur | prev) . . (+2,087). . Jwarner (talk | contribs) (PAD {{#subobject:955a56|Regimen=1}})
 m    16:58 (cur | prev) . . (-2,167). . Jwarner (talk | contribs) (BDD {{#subobject:6ab815|Regimen=1}})
 m   16:55  Acute promyelocytic leukemia‎‎ (2 changes | history) . . (+221). . [Jwarner‎ (2×)]
 m    16:55 (cur | prev) . . (+2,145). . Jwarner (talk | contribs) (Arsenic trioxide, ATRA, Gemtuzumab ozogamicin {{#subobject:533ccc|Regimen=1}})
 m    16:49 (cur | prev) . . (-1,924). . Jwarner (talk | contribs) (Arsenic trioxide & ATRA {{#subobject:2b304d|Regimen=1}})
 m   13:48  Breast cancer, HER2-positive‎ (diff | hist) . . (+43). . Jwarner (talk | contribs)

17 June 2018

 m   22:22  Colon cancer‎ (diff | hist) . . (+149). . Jwarner (talk | contribs) (CapeOx {{#subobject:cf9acc|Regimen=1}})
 m   16:19  Breast cancer‎‎ (5 changes | history) . . (+2,908). . [Jwarner‎ (5×)]
 m    16:19 (cur | prev) . . (+1,300). . Jwarner (talk | contribs) (Docetaxel monotherapy {{#subobject:47db8e|Regimen=1}})
 m    16:07 (cur | prev) . . (+315). . Jwarner (talk | contribs) (Docetaxel monotherapy {{#subobject:45c144|Regimen=1}})
 m    16:04 (cur | prev) . . (+314). . Jwarner (talk | contribs) (Docetaxel monotherapy {{#subobject:1216fd|Regimen=1}})
 m    16:02 (cur | prev) . . (+691). . Jwarner (talk | contribs) (AC {{#subobject:647f67|Regimen=1}})
 m    15:48 (cur | prev) . . (+288). . Jwarner (talk | contribs) (AC {{#subobject:77b0fd|Regimen=1}})
 m   15:58  Complex multipart regimens‎ (diff | hist) . . (+1,486). . Jwarner (talk | contribs) (NSABP B-38)
 m   13:21  Acute promyelocytic leukemia‎ (diff | hist) . . (+784). . Jwarner (talk | contribs) (Arsenic trioxide monotherapy {{#subobject:734f95|Regimen=1}})

14 June 2018

 m   22:56  Breast cancer‎ (diff | hist) . . (-477). . Jwarner (talk | contribs) (References)